0001209191-23-053186.txt : 20231019 0001209191-23-053186.hdr.sgml : 20231019 20231019170113 ACCESSION NUMBER: 0001209191-23-053186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231017 FILED AS OF DATE: 20231019 DATE AS OF CHANGE: 20231019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krasner Alan Seth CENTRAL INDEX KEY: 0001435775 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 231335357 MAIL ADDRESS: STREET 1: C/O CRINETICS PHARMACEUTICALS, INC. STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263744114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-450-6464 MAIL ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-17 0 0001658247 Crinetics Pharmaceuticals, Inc. CRNX 0001435775 Krasner Alan Seth C/O CRINETICS PHARMACEUTICALS, INC. 10222 BARNES CANYON ROAD, BLDG 2 SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer 1 Common Stock 2023-10-17 4 M 0 7000 12.01 A 50210 D Common Stock 2023-10-17 4 S 0 7000 30.00 D 43210 D Non-qualified stock option (Right to Buy) 12.01 2023-10-17 4 M 0 7000 0.00 D 2028-06-15 Common Stock 7000 153473 D Includes 909 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person. 25% of the shares subject to the option vest on June 16, 2019, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. The stock options are also subject to accelerated vesting as set forth in the employment agreement between the Issuer and the Reporting Person. /s/ Marc Wilson, as attorney-in-fact 2023-10-19